scholarly journals An Autologous Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Matrix Scaffold Applied with Bone Marrow Stimulation for Cartilage Repair

2014 ◽  
Vol 20 (17-18) ◽  
pp. 2455-2462 ◽  
Author(s):  
Cheng Tang ◽  
Chengzhe Jin ◽  
Xiaotao Du ◽  
Chao Yan ◽  
Byoung-Hyun Min ◽  
...  
Cartilage ◽  
2014 ◽  
Vol 5 (4) ◽  
pp. 196-202 ◽  
Author(s):  
Shinya Yamasaki ◽  
Hisashi Mera ◽  
Maki Itokazu ◽  
Yusuke Hashimoto ◽  
Shigeyuki Wakitani

Cartilage ◽  
2021 ◽  
pp. 194760352110297
Author(s):  
Kris T. C. Hede ◽  
Bjørn B. Christensen ◽  
Morten L. Olesen ◽  
Jesper Skovhus Thomsen ◽  
Casper B. Foldager ◽  
...  

Objective This study evaluated the effects of mesenchymal stem cell-extracellular vesicles (MSC-EVs) on chondrocyte proliferation in vitro and on cartilage repair in vivo following bone marrow stimulation (BMS) of focal chondral defects of the knee. Methods Six adult Göttingen minipigs received 2 chondral defects in each knee. The pigs were randomized to treatment with either BMS combined with MSC-EVs or BMS combined with phosphate-buffered saline (PBS). Intraarticular injections MSC-EVs or PBS were performed immediately after closure of the surgical incisions, and at 2 and 4 weeks postoperatively. Repair was evaluated after 6 months with gross examination, histology, histomorphometry, immunohistochemistry, and micro-computed tomography (µCT) analysis of the trabecular bone beneath the defect. Results Defects treated with MSC-EVs had more bone in the cartilage defect area than the PBS-treated defects (7.9% vs. 1.5%, P = 0.02). Less than 1% of the repair tissue in both groups was hyaline cartilage. International Cartilage and Joint Preservation Society II histological scoring showed that defects treated with MSC-EVs scored lower on “matrix staining” (20.8 vs. 50.0, P = 0.03), “cell morphology” (35.4 vs. 53.8, P = 0.04), and “overall assessment” (30.8 vs. 52.9, P = 0.03). Consistently, defects treated with MSC-EVs had lower collagen II and higher collagen I areal deposition. Defects treated with MSC-EVs had subchondral bone with significantly higher tissue mineral densities than PBS-treated defects (860 mg HA/cm3 vs. 838 mg HA/cm3, P = 0.02). Conclusion Intraarticular injections of MSC-EVs in conjunction with BMS led to osseous ingrowth that impaired optimal cartilage repair, while enhancing subchondral bone healing.


2013 ◽  
Vol 2 (11) ◽  
pp. 916-927 ◽  
Author(s):  
Christine Linard ◽  
Elodie Busson ◽  
Valerie Holler ◽  
Carine Strup-Perrot ◽  
Jean-Victor Lacave-Lapalun ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Ahmad Jabir Rahyussalim ◽  
Tri Kurniawati ◽  
Andriansjah Rukmana

There was a concern onMycobacterium tuberculosisspreading to the bone marrow, when it was applied on tuberculous spine infection. This research aimed to study the probability of using autologous bone marrow as a source of mesenchymal stem cell for patients with tuberculous spondylitis. As many as nine patients with tuberculous spondylitis were used as samples. During the procedure, the vertebral lesion material and iliac bone marrow aspirates were obtained for acid fast staining, bacteria culture, and PCR (polymerase chain reaction) tests forMycobacterium tuberculosisat the Clinical Microbiology Laboratory of Faculty of Medicine Universitas Indonesia. This research showed that there was a relationship between diagnostic confirmation of tuberculous spondylitis based on the PCR test and bacterial culture on the solid vertebral lesion material with the PCR test and bacterial culture from the bone marrow aspirates. If the diagnostic confirmation concluded positive results, then there was a higher probability that there would be a positive result for the bone marrow aspirates, so that it was not recommended to use autologous bone marrow as a source of mesenchymal stem cell for patients with tuberculous spondylitis unless the PCR and culture examination of the bone marrow showed a negative result.


Sign in / Sign up

Export Citation Format

Share Document